Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain

Zhude Tu, Jinda Fan, Shihong Li, Lynne A. Jones, Jinquan Cui, Prashanth K. Padakanti, Jinbin Xu, Dexing Zeng, Kooresh I. Shoghi, Joel S. Perlmutter, Robert H. MacH

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

2-((4-(1-[ 11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy) methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC 50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [ 11C]CH 3I, ∼45% yield, >92% radiochemical purity, >370 GBq/μmol specific activity at end of bombardment (EOB). Evaluation in Sprague-Dawley rats revealed that [ 11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55. MicroPET studies of [ 11C]MP-10 in monkeys displayed selective uptake in striatum. However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clinical utility of [ 11C]MP-10 as a PDE10A PET tracer.

Original languageEnglish (US)
Pages (from-to)1666-1673
Number of pages8
JournalBioorganic and Medicinal Chemistry
Volume19
Issue number5
DOIs
StatePublished - Mar 1 2011
Externally publishedYes

Fingerprint

Alkylation
Metabolites
Blood-Brain Barrier
Cerebellum
Primates
Haplorhini
Sprague Dawley Rats
Rats
Rodentia
Brain
Imaging techniques
2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline
quinoline

Keywords

  • Carbon-11
  • Huntington's disease
  • MP-10
  • PDE10A
  • PET imaging

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Cite this

Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain. / Tu, Zhude; Fan, Jinda; Li, Shihong; Jones, Lynne A.; Cui, Jinquan; Padakanti, Prashanth K.; Xu, Jinbin; Zeng, Dexing; Shoghi, Kooresh I.; Perlmutter, Joel S.; MacH, Robert H.

In: Bioorganic and Medicinal Chemistry, Vol. 19, No. 5, 01.03.2011, p. 1666-1673.

Research output: Contribution to journalArticle

Tu, Z, Fan, J, Li, S, Jones, LA, Cui, J, Padakanti, PK, Xu, J, Zeng, D, Shoghi, KI, Perlmutter, JS & MacH, RH 2011, 'Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain', Bioorganic and Medicinal Chemistry, vol. 19, no. 5, pp. 1666-1673. https://doi.org/10.1016/j.bmc.2011.01.032
Tu, Zhude ; Fan, Jinda ; Li, Shihong ; Jones, Lynne A. ; Cui, Jinquan ; Padakanti, Prashanth K. ; Xu, Jinbin ; Zeng, Dexing ; Shoghi, Kooresh I. ; Perlmutter, Joel S. ; MacH, Robert H. / Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain. In: Bioorganic and Medicinal Chemistry. 2011 ; Vol. 19, No. 5. pp. 1666-1673.
@article{6e1c436e303e4f8f8ec4afb16e495c47,
title = "Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain",
abstract = "2-((4-(1-[ 11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy) methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC 50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [ 11C]CH 3I, ∼45{\%} yield, >92{\%} radiochemical purity, >370 GBq/μmol specific activity at end of bombardment (EOB). Evaluation in Sprague-Dawley rats revealed that [ 11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55. MicroPET studies of [ 11C]MP-10 in monkeys displayed selective uptake in striatum. However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clinical utility of [ 11C]MP-10 as a PDE10A PET tracer.",
keywords = "Carbon-11, Huntington's disease, MP-10, PDE10A, PET imaging",
author = "Zhude Tu and Jinda Fan and Shihong Li and Jones, {Lynne A.} and Jinquan Cui and Padakanti, {Prashanth K.} and Jinbin Xu and Dexing Zeng and Shoghi, {Kooresh I.} and Perlmutter, {Joel S.} and MacH, {Robert H.}",
year = "2011",
month = "3",
day = "1",
doi = "10.1016/j.bmc.2011.01.032",
language = "English (US)",
volume = "19",
pages = "1666--1673",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "5",

}

TY - JOUR

T1 - Radiosynthesis and in vivo evaluation of [ 11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain

AU - Tu, Zhude

AU - Fan, Jinda

AU - Li, Shihong

AU - Jones, Lynne A.

AU - Cui, Jinquan

AU - Padakanti, Prashanth K.

AU - Xu, Jinbin

AU - Zeng, Dexing

AU - Shoghi, Kooresh I.

AU - Perlmutter, Joel S.

AU - MacH, Robert H.

PY - 2011/3/1

Y1 - 2011/3/1

N2 - 2-((4-(1-[ 11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy) methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC 50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [ 11C]CH 3I, ∼45% yield, >92% radiochemical purity, >370 GBq/μmol specific activity at end of bombardment (EOB). Evaluation in Sprague-Dawley rats revealed that [ 11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55. MicroPET studies of [ 11C]MP-10 in monkeys displayed selective uptake in striatum. However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clinical utility of [ 11C]MP-10 as a PDE10A PET tracer.

AB - 2-((4-(1-[ 11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy) methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC 50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [ 11C]CH 3I, ∼45% yield, >92% radiochemical purity, >370 GBq/μmol specific activity at end of bombardment (EOB). Evaluation in Sprague-Dawley rats revealed that [ 11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55. MicroPET studies of [ 11C]MP-10 in monkeys displayed selective uptake in striatum. However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clinical utility of [ 11C]MP-10 as a PDE10A PET tracer.

KW - Carbon-11

KW - Huntington's disease

KW - MP-10

KW - PDE10A

KW - PET imaging

UR - http://www.scopus.com/inward/record.url?scp=79952186381&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952186381&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2011.01.032

DO - 10.1016/j.bmc.2011.01.032

M3 - Article

C2 - 21315609

AN - SCOPUS:79952186381

VL - 19

SP - 1666

EP - 1673

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 5

ER -